Two Giants Dominate IHE, Making It Riskier Than It Looks
As of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Knowing when to opt for index funds over stocks helps you prioritize diversification and lower maintenance while pursuing gains.
25,835 articlesAs of March 2026, the iShares U.S. Pharmaceuticals ETF is heavily keyed to two drugmakers, exposing investors to outs...
Two Dividend Kings confront mounting cash-flow pressures and strategic shifts as 2026 approaches. This story examines...
Bank of America signals a noticeable pullback in card use across its customers, adding to a growing picture of cautio...
Dynatrace stock plummeted today after earnings beat but soft guidance signaled a cautious path ahead. This article br...
Investing in critical metals blends opportunity with policy risk. This guide breaks down how to evaluate this critica...
Bitcoin holds near the $78,000 mark as on-chain indicators point to rising holder consolidation and shrinking availab...
A broad rally in memory stocks follows a strong Micron session, lifting SanDisk and Western Digital as AI datacenter ...
A line in SpaceX's draft filings has sparked market chatter for its sci-fi tone. The phrase elon musk slipped now dom...
As AI investment accelerates, layoffs already have surpassed last year’s total, with tech cuts leading the pace in Ju...
Citi upgraded AMD to Buy with a $575 price target, sending shares higher and reigniting the AI GPU narrative. Investo...
Analysts rolled out a fresh slate of calls on Block, Cognizant, First Solar and others as markets navigate midweek vo...
Markets are buzzing over signals from Elon Musk as SpaceX soars toward a trillion-dollar valuation and Musk tightens ...